The Enhanced Games has never been short on drama, and this week delivered another whiplash turn: just days after losing its US$800 million antitrust lawsuit against major governing bodies, the breakaway pro-doping competition announced a plan to go public in a merger valuing the company at roughly US$1.2 billion.
The deal, revealed Wednesday, would merge Enhanced with A Paradise Acquisition Corp., a Hong Kong–based SPAC that raised US$200 million in an IPO earlier this year. If shareholders stay on board, the transaction could provide up to US$200 million in fresh capital.
The combined company is expected to list on Nasdaq under the ticker ENHA once the merger closes.
Honestly, it’s a pretty remarkable move for a startup that hasn’t staged a single race. But Enhanced’s pitch to investors has always gone far beyond the four-day Las Vegas meet scheduled for May 2026.
The company describes itself as both a sports entertainment venture and a performance-medicine business, a sort of hybrid between a made-for-TV doping-permitted Games and a subscription-based telehealth provider selling testosterone and other “enhancement” treatments directly to consumers.
The SPAC news also lands at a sensitive moment for the organisation.
A federal judge in New York dismissed its sweeping lawsuit against World Aquatics, USA Swimming and WADA earlier this month, rejecting claims that a new rule banning participation in pro-enhancement competitions amounted to an illegal attempt to crush a rival league. While the court left the door open for an amended complaint, this round goes decisively to the established governing bodies.
Not long after that ruling, Enhanced announced leadership changes.
Co-founder Maximilian Martin has stepped in as CEO, while founder Aron D’Souza, long the public face of the project, has stepped back from day-to-day operations. Billionaire backer Christian Angermayer, already a prominent figure behind the scenes, is taking over as executive chairman.
Even with the lawsuit setback, the company’s financial momentum hasn’t seemed to slow down.
Enhanced has pulled in a US$40 million private placement ahead of the merger, largely from existing investors. Its backers include Peter Thiel, Trump-aligned venture firm 1789 Capital, and a collection of tech and entertainment figures.
The Games themselves remain the project’s biggest lightning rod.
Scheduled for Memorial Day weekend in Las Vegas, the inaugural event is said to feature sprinting, swimming, and weightlifting, and is framed as a showcase for athletes who want to compete while using performance-enhancing drugs under medical supervision.
The prize purses are enormous, especially by Olympic-sport standards, including US$250,000 for event winners and seven-figure bonuses for world records. Olympic 100m champion Fred Kerley and world champion swimmer Ben Proud are among the athletes who’ve publicly committed.
Traditional sporting bodies have taken a much harder line. World Aquatics has already said participating athletes will be ineligible for its events. World Athletics officials have echoed that stance. Anti-doping leaders have called the concept dangerous and ethically indefensible.
For Enhanced, going public is a way to harden the project into something lasting.
Now, a successful SPAC merger doesn’t guarantee the event will work; plenty of SPACs have fizzled in the past, but it does give the company something it has never had before: a large pool of capital, a real corporate structure, and the validation that comes with being listed on a major exchange.
What remains undecided is whether this experiment can survive the political pressure, the scientific scrutiny, and the simple question of whether fans actually want to watch a doping-permitted Games.
But with a billion-dollar valuation now on the table, the Enhanced Games is no longer just a loud idea on social media. It’s actually somewhat of a well-funded business making a very public bet that sport’s future may look a lot stranger (and a lot more pharmaceutical) than its past.
